IgE‐binding molecules (Mac‐2/ϵBP) expressed by human eosinophils. Implication in IgE‐dependent eosinophil cytotoxicity
The DOI matches its Crossref record.
Abstract
Macrophage cell‐surface protein 2 (Mac‐2), a galactose specific S‐type lectin identified in inflammatory macrophages, presents a high degree of homology with the rat IgE‐binding protein (ϵBP). In the present study, we show by different experimental approaches that human eosinophils can express Mac‐2/ϵBP. Flow cytometry analysis revealed that a large proportion of eosinophilic patients expressing binding sites for IgE on their eosinophil membrane, were able to bind anti‐Mac‐2 monoclonal antibody (mAb). Northern blot performed with eosinophil RNA hybridized with the human Mac‐2 or ϵBP cDNA probes revealed that eosinophils presented a unique transcript at 1.2 kb. Immunoprecipitation of eosinophil extracts with anti‐Mac‐2 mAb revealed the presence of a molecule of 29 kDa corresponding to Mac‐2 protein, as well as one additional molecule of 15 kDa, absent from control alveolar macrophages. The function of these molecules was investigated in a radiolabeled IgE binding assay. Anti‐Mac‐2 mAb as well as galactose and lactose saccharides significantly inhibited the binding of radiolabeled human myeloma IgE protein to eosinophils. Moreover, the dose‐dependent inhibition by anti‐Mac‐2 mAb of IgE‐dependent eosinophil‐mediated cytotoxicity towards parasite targets indicated the role of these IgE‐binding molecules in the function of human eosinophils. These results suggest that in addition to transmembrane receptors, lectin‐type molecules can participate in the IgE‐dependent effector function of eosinophils.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
IgE and mast cells in allergic disease
Galli, S. J., & Tsai, M. (2012) · Nature Medicine · doi:10.1038/nm.2755 · Cited by 1,799
Galectin-3: An open-ended story
Dumic, J., Dabelic, S., & Flögel, M. (2006) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2005.12.020 · Cited by 1,169
Galectins: regulators of acute and chronic inflammation
Liu, F., & Rabinovich, G. A. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05131.x · Cited by 405
Self-citationGalectin-3: One Molecule for an Alphabet of Diseases, from A to Z
Sciacchitano, S., Lavra, L., Morgante, A., Ulivieri, A., Magi, F., De Francesco, G., Bellotti, C., Salehi, L., & Ricci, A. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19020379 · Cited by 377
Extracellular functions of galectin-3
Ochieng, J., Furtak, V., & Lukyanov, P. (2002) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000014082.99675.2f · Cited by 370
Pharmacology of the Eosinophil
Giembycz, M. A., & Lindsay, M. A. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01404-2 · Cited by 351
Eosinophils: multifaceted biological properties and roles in health and disease
Kita, H. (2011) · Immunological Reviews · doi:10.1111/j.1600-065x.2011.01026.x · Cited by 336
Matsumoto, R., Matsumoto, H., Seki, M., Hata, M., Asano, Y., Kanegasaki, S., Stevens, R. L., & Hirashima, M. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16976 · Cited by 302
LacdiNAc-glycans constitute a parasite pattern for galectin-3-mediated immune recognition
van den Berg, T. K., Honing, H., Franke, N., van Remoortere, A., Schiphorst, W. E. C. M., Liu, F.-T., Deelder, A. M., Cummings, R. D., Hokke, C. H., & van Die, I. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.3.1902 · Cited by 170
Self-citationPOU‐BARRETO, C., QUISPE‐RICALDE, M. A., MORCHÓN, R., VÁZQUEZ, C., GENCHI, M., POSTIGO, I., VALLADARES, B., & SIMÓN, F. (2008) · Parasite Immunology · doi:10.1111/j.1365-3024.2008.01060.x · Cited by 20
Metadata
- Authors
- Truong, M., Gruart, V., Liu, F., Prin, L., Capron, A., & Capron, M.
- Venue
- European Journal of Immunology
- Publisher
- Wiley
- Published
- 1993-12
- Volume
- 23
- Issue
- 12
- Pages
- 3230-3235
- ISSN
- 0014-2980 (ISSN-L)
- 1521-4141
- OpenAlex
- W1966520192
- Cited by
- 97
- References
- 0
- FWCI
- 3.12
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.